Constellation Software: Rich Multiple Presents A Riddle
Constellation Software shares appreciated 24% in US dollar terms in 2024 and we've had big goings-on at Constellation. Click here to read more.
The National Law Review1d
EPA Releases Compliance Guidance for Workplace Chemical Protection Requirements in TSCA Risk Management Rules
On January 16, 2025, the U.S. Environmental Protection Agency (EPA) released a compliance guide to assist the regulated ...
pharmaphorum2d
Stopwatch starts on reviews of GSK's long-acting asthma drug
Depemokimab is a follow-up to GSK's Nucala (mepolizumab), a once-monthly IL-5 inhibitor approved for severe asthma, CRSwNP, ...
PharmiWeb2d
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP
GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications. The submitted ...
PharmiWeb2d
Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP
GSK plc (LSE/NYSE: GSK) today announced that new drug applications have been accepted for review by the China National Medical Products Administration and submitted to the Japanese Ministry of Health, ...